Winthrop Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19
Closed -$7K 348
2026
Q1
$7K Hold
19
﹤0.01% 247
2025
Q4
$6K Buy
+19
New +$6.03K ﹤0.01% 250
2025
Q3
Sell
-409
Closed -$114K 336
2025
Q2
$114K Buy
+409
New +$116K 0.03% 147
2025
Q1
Sell
-1,147
Closed -$297K 332
2024
Q4
$297K Buy
1,147
+160
+16% +$47.5K 0.08% 114
2024
Q3
$318K Sell
987
-13
-1% -$4.25K 0.15% 54
2024
Q2
$312K Buy
+1,000
New +$294K 0.16% 51

Other funds holding AMGN

Winthrop Capital Management's AMGN Position: Q2 2026 in Review

Winthrop Capital Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 19 shares — an estimated $7K sold.

Winthrop Capital Management first reported a position in AMGN in Q2 2024 and held it in 6 quarters. The position peaked at $318K in Q3 2024. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Winthrop Capital Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Winthrop Capital Management sold 19 Amgen shares in Q2 2026, an estimated $7K.
  • Winthrop Capital Management first reported a position in Amgen in Q2 2024 and held it in 6 quarters.
  • Winthrop Capital Management's Amgen position peaked at $318K in Q3 2024.
  • 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.